Short answer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) filed an 8-K current report with the SEC on June 4, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Board approved 16,000,000 additional common shares for the 2020 Equity Incentive Plan, subject to stockholder approval.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board approved 16,000,000 additional common shares for the 2020 Equity Incentive Plan, subject to stockholder approval
- Larger equity pool increases potential employee compensation flexibility and future dilution risk
- Compensation committee recommendation signals support for expanded equity-based incentives
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 65% shareholder participation, with 203,009,375 of 310,487,099 shares represented
- All six Class III director nominees elected to serve until the 2027 annual meeting
- Ernst & Young LLP appointment ratified for fiscal year ending December 31, 2026
- Executive compensation approved in a non-binding advisory vote
- 2020 Equity Incentive Plan amended to increase reserved common shares, potentially expanding equity dilution capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K filings
Get the next PACB 8-K as it lands
Follow PACB for push alerts, or ask the research agent what this filing means.